Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ZYDUS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 36
  • 0 comments

FDA approve CHLORPROMAZINE HYDROCHLORIDE

Comment Full text

JANSSEN PRODS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 41
  • 0 comments

FDA approve RILPIVIRINE HYDROCHLORIDE

Comment Full text

APOTEX

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 33
  • 0 comments

FDA approve DASATINIB

Comment Full text

PERRIGO R AND D

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 37
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

MIKART

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 34
  • 0 comments

FDA approve ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

Comment Full text

PERRIGO R AND D

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 41
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

AMNEAL PHARMS CO

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 44
  • 0 comments

FDA approve ETODOLAC

Comment Full text

JANSSEN PRODS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 32
  • 0 comments

FDA approve RILPIVIRINE

Comment Full text

PERRIGO R AND D

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 39
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

PERRIGO R AND D

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 38
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text
  • Previous
  • 503
  • 504
  • 505
  • 506
  • 507
  • Next

Search

News categories

  • Technical Exchange News(13021)
  • Event(6229)
  • SEC News(322463)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(181716)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin